Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disparities in patient access and disease targets in upfront clinical trials for gynecologic cancers
    Meeting Abstract

    Albright, B.; Moss, H.; Aviki, E.; Chino, F.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Isolated vaginal recurrences in women with stage I endometrial cancer
    Meeting Abstract

    Rios-Doria, E.; Cun, H.; Filippova, O.; Mueller, J.; Alektiar, K.; Ellenson, L.; Makker, V.; Lakhman, Y.; Leitao, M.; Jhingran, A.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Non-exenterative surgical management of recurrent endometrial carcinoma: Patient characteristics and outcomes
    Meeting Abstract

    Moukarzel, L.; Braxton, K.; Zhou, Q.; Pedra Nobre, S.; Iasonos, A.; Tew, W.; Abu-Rustum, N.; Leitao, M.; Chi, D.; Mueller, J.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Secondary efficacy results from the phase II LIGHT study
    Meeting Abstract

    Cadoo, K.; Simpkins, F.; Mathews, C.; Liu, Y.; Provencher, D.; McCormick, C.; ElNaggar, A.; Kabil, N.; Bennett, J.; Yu, H.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Secondary safety results from the phase II LIGHT study
    Meeting Abstract

    Cadoo, K.; Simpkins, F.; Mathews, C.; Altman, A.; Gilbert, L.; Liu, Y.; Black, D.; Munley, J.; Kabil, N.; Bennett, J.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • 10-year survival in patients diagnosed with high-grade epithelial ovarian cancer: A new metric for a new millennium
    Meeting Abstract

    Filippova, O.; Straubhar, A.; Lugo Santiago, N.; Zivanovic, O.; Gardner, G.; Tew, W.; O'Cearbhaill, R.; Grisham, R.; Sonoda, Y.; Roche, K. L.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • A modern day experience with Brunschwig's operation: Advancements in pelvic exenteration
    Meeting Abstract

    Rios-Doria, E.; Filippova, O.; Straubhar, A.; Chi, A.; Awowole, I.; Sandhu, J.; Broach, V.; Mueller, J.; Gardner, G.; Jewell, E.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer
    Meeting Abstract

    Lim, S.; Moss, H.; Havrilesky, L.; O'Cearbhaill, R.; Abu-Rustum, N.; Liang, M.; Wright, J.; Aviki, E.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Association of BRCA1/2, homologous recombination deficiency, and PD-L1 with clinical outcomes in patients receiving atezolizumab versus placebo combined with carboplatin, paclitaxel, and bevacizumab for newly diagnosed ovarian cancer: Exploratory analyses of IMagyn050/GOG3015/ENGOT-ov39
    Meeting Abstract

    Landen, C.; Molinero, L.; Sehouli, J.; Miller, A.; Moore, K.; Taskiran, C.; Bookman, M.; Lindemann, K.; Anderson, C.; Berger, R.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • CDKN2A loss-of-function genetic alterations in uterine sarcoma: Prognostic implications and potential therapeutic target
    Meeting Abstract

    Miller, K.; Chui, H.; Chiang, S.; Ellenson, L.; Weigelt, B.; Hensley, M.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save